RhumbLine Advisers
KOD icon

RhumbLine Advisers’s Kodiak Sciences KOD Stock Holding History

RhumbLine Advisers’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
50,198
+2,240
+5% +$87.2K ﹤0.01% 1947
2026
Q1 		$1.83M Buy
47,958
+4,714
+11% +$122K ﹤0.01% 1903
2025
Q4 		$1.21M Sell
43,244
-5,215
-11% -$107K ﹤0.01% 2133
2025
Q3 		$793K Sell
48,459
-475
-1% -$4.09K ﹤0.01% 2387
2025
Q2 		$183K Sell
48,934
-3,340
-6% -$11.8K ﹤0.01% 3273
2025
Q1 		$147K Buy
52,274
+805
+2% +$4.38K ﹤0.01% 3264
2024
Q4 		$512K Buy
51,469
+1,232
+2% +$7.08K ﹤0.01% 2666
2024
Q3 		$131K Sell
50,237
-6,274
-11% -$16.7K ﹤0.01% 3423
2024
Q2 		$133K Buy
56,511
+586
+1% +$1.99K ﹤0.01% 3420
2024
Q1 		$294K Buy
55,925
+856
+2% +$4.19K ﹤0.01% 2990
2023
Q4 		$167K Buy
55,069
+314
+0.6% +$698 ﹤0.01% 3271
2023
Q3 		$98.6K Sell
54,755
-1,819
-3% -$6.42K ﹤0.01% 3469
2023
Q2 		$390K Buy
56,574
+1,890
+3% +$11.6K ﹤0.01% 2850
2023
Q1 		$339K Buy
54,684
+1,128
+2% +$7.89K ﹤0.01% 2576
2022
Q4 		$383K Buy
53,556
+270
+0.5% +$1.94K ﹤0.01% 2591
2022
Q3 		$412K Buy
53,286
+1,842
+4% +$17.9K ﹤0.01% 2582
2022
Q2 		$393K Buy
51,444
+15,578
+43% +$109K ﹤0.01% 2616
2022
Q1 		$277K Buy
35,866
+396
+1% +$15.5K ﹤0.01% 2664
2021
Q4 		$3.01M Sell
35,470
-430
-1% -$43.7K ﹤0.01% 1660
2021
Q3 		$3.45M Buy
35,900
+882
+3% +$81.5K ﹤0.01% 1582
2021
Q2 		$3.26M Sell
35,018
-2,097
-6% -$201K ﹤0.01% 1676
2021
Q1 		$4.21M Sell
37,115
-2,695
-7% -$368K 0.01% 1503
2020
Q4 		$5.85M Buy
39,810
+3,475
+10% +$387K 0.01% 1264
2020
Q3 		$2.15M Sell
36,335
-7,384
-17% -$371K ﹤0.01% 1643
2020
Q2 		$2.37M Buy
43,719
+7,454
+21% +$420K ﹤0.01% 1634
2020
Q1 		$1.73M Buy
36,265
+6,777
+23% +$407K ﹤0.01% 1623
2019
Q4 		$2.12M Buy
29,488
+5,945
+25% +$216K ﹤0.01% 1772
2019
Q3 		$339K Buy
23,543
+866
+4% +$11.3K ﹤0.01% 2518
2019
Q2 		$265K Buy
+22,677
New +$202K ﹤0.01% 2666

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

RhumbLine Advisers's KOD Position: Q2 2026 in Review

RhumbLine Advisers increased its Kodiak Sciences (KOD) stake by 4.7% in Q2 2026, buying an estimated $87.2K and bringing the position to 50,198 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

RhumbLine Advisers first reported a position in KOD in Q2 2019 and has held it in 29 quarters since. The position peaked at $5.85M in Q4 2020. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • RhumbLine Advisers held 50,198 shares of Kodiak Sciences worth $1.96M as of Q2 2026.
  • RhumbLine Advisers bought 2,240 Kodiak Sciences shares in Q2 2026, an estimated $87.2K.
  • Kodiak Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1947 holding.
  • RhumbLine Advisers first reported a position in Kodiak Sciences in Q2 2019 and has held it in 29 quarters since.
  • RhumbLine Advisers's Kodiak Sciences position peaked at $5.85M in Q4 2020.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.